BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 140 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $532 | +3.9% | 73,765 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $512 | -13.8% | 73,765 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $594 | -26.8% | 73,765 | 0.0% | 0.00% | -50.0% |
Q4 2022 | $811 | -99.9% | 73,765 | 0.0% | 0.00% | -33.3% |
Q3 2022 | $895,000 | +14.6% | 73,765 | 0.0% | 0.00% | +50.0% |
Q2 2022 | $781,000 | -35.6% | 73,765 | 0.0% | 0.00% | -33.3% |
Q1 2022 | $1,213,000 | +35.7% | 73,765 | +10.0% | 0.00% | +50.0% |
Q4 2021 | $894,000 | -3.2% | 67,065 | +2.8% | 0.00% | -33.3% |
Q3 2021 | $924,000 | -7.1% | 65,265 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $995,000 | +54.7% | 65,265 | 0.0% | 0.00% | +50.0% |
Q1 2021 | $643,000 | -12.4% | 65,265 | -38.0% | 0.00% | -33.3% |
Q4 2020 | $734,000 | +3.2% | 105,265 | -41.6% | 0.00% | 0.0% |
Q3 2020 | $711,000 | +611.0% | 180,265 | +472.3% | 0.00% | +200.0% |
Q3 2019 | $100,000 | -56.3% | 31,500 | -50.0% | 0.00% | 0.0% |
Q2 2019 | $229,000 | -17.0% | 63,000 | +63.6% | 0.00% | -50.0% |
Q1 2019 | $276,000 | +10.0% | 38,500 | +22.2% | 0.00% | 0.0% |
Q4 2018 | $251,000 | -9.1% | 31,500 | -18.2% | 0.00% | 0.0% |
Q3 2018 | $276,000 | +20.5% | 38,500 | -2.5% | 0.00% | +100.0% |
Q2 2018 | $229,000 | +21.2% | 39,500 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $189,000 | +96.9% | 39,500 | +12.9% | 0.00% | 0.0% |
Q1 2016 | $96,000 | -75.3% | 35,000 | -5.4% | 0.00% | -75.0% |
Q4 2015 | $388,000 | -6.7% | 37,000 | +1.4% | 0.00% | -20.0% |
Q3 2015 | $416,000 | -20.5% | 36,500 | +4.3% | 0.01% | -16.7% |
Q2 2015 | $523,000 | +72.0% | 35,000 | +3.9% | 0.01% | +50.0% |
Q1 2015 | $304,000 | -34.9% | 33,700 | -12.7% | 0.00% | -33.3% |
Q4 2014 | $467,000 | +13.3% | 38,600 | -8.3% | 0.01% | 0.0% |
Q3 2014 | $412,000 | -19.2% | 42,100 | +5.2% | 0.01% | -25.0% |
Q2 2014 | $510,000 | +32.1% | 40,000 | +9.6% | 0.01% | +33.3% |
Q1 2014 | $386,000 | – | 36,500 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 7,637,700 | $77,675,000 | 7.44% |
Burrage Capital Management LLC | 864,916 | $8,796,000 | 7.13% |
ORACLE INVESTMENT MANAGEMENT INC | 2,367,670 | $24,079,000 | 3.61% |
HealthCor Management, L.P. | 4,886,440 | $49,695,000 | 1.76% |
Ghost Tree Capital, LLC | 500,000 | $5,085,000 | 1.20% |
Integral Health Asset Management, LLC | 400,000 | $4,068,000 | 1.16% |
Lisanti Capital Growth, LLC | 472,520 | $4,806,000 | 0.62% |
Parkman Healthcare Partners LLC | 244,680 | $2,488,000 | 0.58% |
Baker Brothers Advisors | 12,710,818 | $129,269,000 | 0.56% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,605,380 | $26,497,000 | 0.56% |